Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
QuintilesIMS
McKesson
Farmers Insurance
US Army
Deloitte
Johnson and Johnson
Baxter
Fish and Richardson
US Department of Justice

Generated: October 19, 2017

DrugPatentWatch Database Preview

AFEDITAB CR Drug Profile

« Back to Dashboard

Which patents cover Afeditab Cr, and what generic Afeditab Cr alternatives are available?

Afeditab Cr is a drug marketed by Watson Labs Teva and Watson Labs and is included in two NDAs.

The generic ingredient in AFEDITAB CR is nifedipine. There are thirty-nine drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the nifedipine profile page.

Summary for Tradename: AFEDITAB CR

US Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list4
Bulk Api Vendors: see list89
Patent Applications: see list5,699
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AFEDITAB CR at DailyMed

Pharmacology for Tradename: AFEDITAB CR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Teva
AFEDITAB CR
nifedipine
TABLET, EXTENDED RELEASE;ORAL075128-001Mar 10, 2000AB1RXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
AFEDITAB CR
nifedipine
TABLET, EXTENDED RELEASE;ORAL075659-001Oct 26, 2001AB1RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Accenture
QuintilesIMS
Covington
Cantor Fitzgerald
Argus Health
Federal Trade Commission
Johnson and Johnson
Cipla
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot